BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2971653)

  • 41. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts.
    Kiess W; Haskell JF; Lee L; Greenstein LA; Miller BE; Aarons AL; Rechler MM; Nissley SP
    J Biol Chem; 1987 Sep; 262(26):12745-51. PubMed ID: 2957378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man.
    Hardouin S; Hossenlopp P; Segovia B; Seurin D; Portolan G; Lassarre C; Binoux M
    Eur J Biochem; 1987 Dec; 170(1-2):121-32. PubMed ID: 2961563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
    Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM
    Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simple and efficient scheme for the purification of insulin-like growth factor II from human bone matrix extract.
    Mohan S
    Growth Factors; 1990; 2(4):267-71. PubMed ID: 2337472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.
    Ernst M; Rodan GA
    Endocrinology; 1990 Aug; 127(2):807-14. PubMed ID: 2164921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factor I/somatomedin-C: a rapid isolation procedure with FPLC.
    Pfeifle B; Maier V; Ditschuneit H
    Prep Biochem; 1985; 15(5):291-307. PubMed ID: 3834419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Purification and characterization of insulin-like growth factor binding proteins (IGF-BP) in amniotic fluid--existence of a 160K IGF-BP].
    Iwashita M; Watanabe M; Adachi T; Takeda Y; Sakamoto S
    Nihon Naibunpi Gakkai Zasshi; 1990 Jun; 66(6):636-48. PubMed ID: 1696916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulation of DNA synthesis in chicken muscle satellite cells by insulin and insulin-like growth factors: evidence for exclusive mediation by a type-I insulin-like growth factor receptor.
    Duclos MJ; Wilkie RS; Goddard C
    J Endocrinol; 1991 Jan; 128(1):35-42. PubMed ID: 1847964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and purification of truncated insulin-like growth factor I from porcine uterus. Evidence for high biological potency.
    Ogasawara M; Karey KP; Marquardt H; Sirbasku DA
    Biochemistry; 1989 Mar; 28(6):2710-21. PubMed ID: 2730884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of insulin-like growth factor I with porcine thyroid cells cultured in monolayer.
    Saji M; Tsushima T; Isozaki O; Murakami H; Ohba Y; Sato K; Arai M; Mariko A; Shizume K
    Endocrinology; 1987 Aug; 121(2):749-56. PubMed ID: 3036481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.
    Rosenfeld RG; Ceda G; Cutler CW; Dollar LA; Hoffman AR
    Endocrinology; 1985 Nov; 117(5):2008-16. PubMed ID: 2995005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.
    Rutanen EM; Pekonen F; Mäkinen T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):173-80. PubMed ID: 2961785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.
    De Leon DD; Bakker B; Wilson DM; Hintz RL; Rosenfeld RG
    Biochem Biophys Res Commun; 1988 Apr; 152(1):398-405. PubMed ID: 2451917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a subtype of insulin-like growth factor I receptor in brain.
    Heidenreich KA; Freidenberg GR; Figlewicz DP; Gilmore PR
    Regul Pept; 1986 Nov; 15(4):301-10. PubMed ID: 2948220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.
    Gauguin L; Klaproth B; Sajid W; Andersen AS; McNeil KA; Forbes BE; De Meyts P
    J Biol Chem; 2008 Feb; 283(5):2604-13. PubMed ID: 18048361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factors in sheep thyroid cells: action, receptors and production.
    Bachrach LK; Eggo MC; Hintz RL; Burrow GN
    Biochem Biophys Res Commun; 1988 Aug; 154(3):861-7. PubMed ID: 2970260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth factor binding and bioactivity in human kidney epithelial cell cultures.
    Gansler T; Hsu WC; Gramling TS; Robinson KA; Buse MG; Blocker N; Roy L; Green S; Garvin AJ; Sens DA
    In Vitro Cell Dev Biol; 1990 Mar; 26(3 Pt 1):285-90. PubMed ID: 2156796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
    Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
    Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.
    King GL; Goodman AD; Buzney S; Moses A; Kahn CR
    J Clin Invest; 1985 Mar; 75(3):1028-36. PubMed ID: 2984251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
    Lee CY; Rechler MM
    Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.